F
Federico Bardazzi
Researcher at University of Bologna
Publications - Â 225
Citations - Â 3037
Federico Bardazzi is an academic researcher from University of Bologna. The author has contributed to research in topics: Psoriasis & Medicine. The author has an hindex of 27, co-authored 183 publications receiving 2531 citations.
Papers
More filters
Journal ArticleDOI
Drug-induced hair loss and hair growth. Incidence, management and avoidance.
TL;DR: Both hirsutism and hypertrichosis may be associated with drug administration, and drugs most commonly responsible for the development of hirsUTism include testosterone, danazol, corticotrophin, metyrapone, anabolic steroids and glucocorticoids.
Journal ArticleDOI
Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis.
Paolo Gisondi,Gianfranco Altomare,Fabio Ayala,Federico Bardazzi,Luca Bianchi,Andrea Chiricozzi,Antonio Costanzo,Andrea Conti,Paolo Dapavo,C. De Simone,Caterina Foti,Luigi Naldi,A. Offidani,Andrea Parodi,Stefano Piaserico,Francesca Prignano,Franco Rongioletti,Luca Stingeni,Marina Talamonti,Giampiero Girolomoni +19 more
TL;DR: Recommendations on the treatment of psoriasis in special patient populations were agreed and the use, screening and monitoring of systemic therapies were based on the 2015 S3 European Dermatology Forum/European Academy of Dermatologists and Venereology psorosis guidelines.
Journal ArticleDOI
Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum.
Nardo Zaias,Antonella Tosti,Gerbert Rebell,Rosella Morelli,Federico Bardazzi,Harlan Bieley,Martin Zaiac,Brad Glick,Bruce Paley,Miguel Allevato,Robert Baran +10 more
TL;DR: The patient demonstrates that ~//8 CTCL can present both clinically and histologically as typical mycosis fungoides, and supports the view that definition of a new clinicopathologic entity is not indicated.
Journal ArticleDOI
Treatment of dermatophyte nail infections: An open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy
Antonella Tosti,Bianca Maria Piraccini,Caterina Stinchi,Nicola Venturo,Federico Bardazzi,Maria Delia Colombo +5 more
TL;DR: The percentage of patients who were mycologically cured was higher in the continuous terbINAfine group than in the intermittent terbinafine and itraconazole groups, but statistical analysis did not reveal any significant difference between these cure rates.
Journal ArticleDOI
Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy
Federico Bardazzi,Riccardo Balestri,Elena Baldi,Angela Antonucci,S De Tommaso,Annalisa Patrizi +5 more
TL;DR: Further studies are needed to understand if the poor response observed in heavier patients is due to biological drugs pharmacokinetics or because therapy should be BMI based rather than administered in fixed doses, posing then an ethical consideration.